Key points are not available for this paper at this time.
and its enantiomers exhibited limited off-target effects, resulting in a safe profile and highlighting their potential utility as next-generation utrophin modulators suitable for progression toward a future DMD therapy.
Babbs et al. (Thu,) studied this question.